Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

alpha-Fetoprotein screening.

B K Burton

    Advances in Pediatrics
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Maternal serum alpha-fetoprotein (MSAFP) screening is becoming standard prenatal care. This cost-effective method screens for neural tube defects and aids in detecting Down's syndrome, improving maternal and infant health.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Home visits in the Danish High Risk and Resilience Study - VIA 7: assessment of the home environment of 508 7-year-old children born to parents diagnosed with schizophrenia or bipolar disorder.

    Acta psychiatrica Scandinavica·2019
    Same author

    Association of the missense variant p.Arg203Trp in PACS1 as a cause of intellectual disability and seizures.

    Clinical genetics·2017
    Same author

    Inhibition of protein kinase C (PKC) response of voltage-gated calcium (Cav)2.2 channels expressed in Xenopus oocytes by Cavβ subunits.

    Neuroscience·2014
    Same author

    The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study.

    Journal of inherited metabolic disease·2007
    Same author

    Alexander disease with serial MRS and a new mutation in the glial fibrillary acidic protein gene.

    Neurology·2003
    Same author

    Urea cycle disorders.

    Clinics in liver disease·2001
    Same journal

    Two Steps Forward-One Step Back: Keeping Pace with Advances.

    Advances in pediatrics·2025
    Same journal

    Pediatric Lymphadenopathy.

    Advances in pediatrics·2025
    Same journal

    Vascular and Gastrointestinal Access in Children.

    Advances in pediatrics·2025
    Same journal

    The Ouchless Pediatric Emergency Department.

    Advances in pediatrics·2025
    Same journal

    Seizures and Shaking in Newborns and Babies.

    Advances in pediatrics·2025
    Same journal

    Procalcitonin in Pediatric Emergency Medicine.

    Advances in pediatrics·2025
    See all related articles

    Area of Science:

    • Obstetrics and Gynecology
    • Medical Diagnostics
    • Biochemistry

    Background:

    • Maternal serum alpha-fetoprotein (MSAFP) screening is increasingly integrated into routine prenatal care.
    • The benefits of MSAFP screening have surpassed initial expectations.
    • Understanding factors influencing MSAFP levels during pregnancy is continuously advancing.

    Purpose of the Study:

    • To highlight the expanding role and benefits of MSAFP screening in prenatal diagnostics.
    • To emphasize its utility beyond neural tube defect screening.
    • To discuss its potential in identifying chromosomal abnormalities like Down's syndrome.

    Main Methods:

    • This section is not detailed in the abstract, but implies the use of biochemical analysis of maternal serum.

    Related Experiment Videos

  • Focuses on the application and interpretation of MSAFP levels.

    • Main Results:

    • MSAFP screening offers an efficient and cost-effective method for detecting fetal neural tube defects.
    • It provides valuable information for identifying other pregnancy complications.
    • MSAFP screening shows potential for early detection of Down's syndrome and other chromosomal abnormalities.

    Conclusions:

    • MSAFP screening is a valuable tool in prenatal care, extending beyond its initial applications.
    • Ongoing research and refinements will further enhance its utility.
    • The technology significantly contributes to improving the health and well-being of mothers and infants.